Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Gilles Devouassoux"'
Autor:
Clairelyne Dupin, Solène Valéry, Laurent Guilleminault, Gilles Devouassoux, Marine Merveilleau, Maud Russier, Gisèle Mourin, Johana Pradelli, Philippe Bonniaud, Mathilde Le Brun, Esther Ebstein, Pierre-Antoine Juge, Agnès Lillo-Lelouet, Camille Taillé
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/c33d024efbb940d499fcc7df4e710e94
Autor:
Romain Kessler, Alain Didier, Mathieu Molimard, A Bourdin, Thierry Chinet, Chantal Raherison, Nicolas Roche, Carey Meredith Suehs, Maéva Zysman, Cécile Chenivesse, Pierre-Régis Burgel, F Couturaud, Gaëtan Deslee, Patrick Berger, Gilles Devouassoux, Christophe Brousse, Philippe Devillier, Pascal Chanez, Yan Martinat, Olivier Le Rouzic
Publikováno v:
BMJ Open, Vol 10, Iss 7 (2020)
Objectives Presently, those outcomes that should be prioritised for chronic obstructive pulmonary disease (COPD) exacerbation studies remain unclear. In order to coordinate multicentre studies on eosinophilia-driven corticosteroid therapy for patient
Externí odkaz:
https://doaj.org/article/69426d2d97cc462995eaf4bdbba9be93
Autor:
Chloe I. Bloom, Christine M. Graham, Matthew P. R. Berry, Fotini Rozakeas, Paul S. Redford, Yuanyuan Wang, Zhaohui Xu, Katalin A. Wilkinson, Robert J. Wilkinson, Yvonne Kendrick, Gilles Devouassoux, Tristan Ferry, Makoto Miyara, Diane Bouvry, Valeyre Dominique, Guy Gorochov, Derek Blankenship, Mitra Saadatian, Phillip Vanhems, Huw Beynon, Rama Vancheeswaran, Melissa Wickremasinghe, Damien Chaussabel, Jacques Banchereau, Virginia Pascual, Ling-pei Ho, Marc Lipman, Anne O’Garra
Publikováno v:
PLoS ONE, Vol 8, Iss 8 (2013)
Externí odkaz:
https://doaj.org/article/f4101c8dee70460e8743b735c01a8725
Autor:
Chloe I Bloom, Christine M Graham, Matthew P R Berry, Fotini Rozakeas, Paul S Redford, Yuanyuan Wang, Zhaohui Xu, Katalin A Wilkinson, Robert J Wilkinson, Yvonne Kendrick, Gilles Devouassoux, Tristan Ferry, Makoto Miyara, Diane Bouvry, Dominique Valeyre, Guy Gorochov, Derek Blankenship, Mitra Saadatian, Phillip Vanhems, Huw Beynon, Rama Vancheeswaran, Melissa Wickremasinghe, Damien Chaussabel, Jacques Banchereau, Virginia Pascual, Ling-Pei Ho, Marc Lipman, Anne O'Garra
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70630 (2013)
New approaches to define factors underlying the immunopathogenesis of pulmonary diseases including sarcoidosis and tuberculosis are needed to develop new treatments and biomarkers. Comparing the blood transcriptional response of tuberculosis to other
Externí odkaz:
https://doaj.org/article/978b5ed701e14910ae37827c1197537a
Autor:
José María Echave-Sustaeta María-Tomé, Peter Lange, David A. Lomas, Fernando J. Martinez, Holly Quasny, MeiLan K. Han, C. Elaine Jones, Mark T. Dransfield, Nicola A. Hanania, Arnaud Bourdin, Robert A. Wise, L. Saïl, Henrik Watz, David M.G. Halpin, Gilles Devouassoux, Gerard J. Criner, Byron Thomashow, Neil R.W. Martin, Ravi Kalhan, Thomas Siler, David A. Lipson, Dave Singh, Sally Lettis
Publikováno v:
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Chronic Obstr Pulm Dis
Universidad Europea (UEM)
Chronic Obstr Pulm Dis
Background: The InforMing the Pathway of COPD Treatment (IMPACT) trial demonstrated lower moderate/ severe exacerbation rates with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI or UMEC/VI in patients with chronic obstructive p
Autor:
Christos Chouaid, Gaëlle Nachbaur, Manon Belhassen, Eric Van Ganse, F. Dalon, L. Saïl, Camille Correia Da Silva, Gilles Devouassoux, F. Jacoud
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:2905-2915
Purpose This study assessed therapy persistence in patients with chronic obstructive pulmonary disease (COPD) in France, and the impact of non-persistence on exacerbations and described COPD-related healthcare resource use (HRU). Methods Patients age
Autor:
W. Chumbi-Flores, Gilles Devouassoux, C.-M. Gaillard, L. Kiakouama-Maleka, F. Craighero, L. Gaillot-Durand
Publikováno v:
Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36, pp.902-905. ⟨10.1016/j.rmr.2019.05.040⟩
Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36, pp.902-905. ⟨10.1016/j.rmr.2019.05.040⟩
Tyrosine kinase inhibitors are now major actors for the treatment of non-small-cell metastatic lung cancers where ROS 1 gene rearrangement is present. Because of the rapid development of these new therapies, developing information about their monitor
Autor:
Sophie Pereira, Nathalie Bautin, Juliette Verhille, Philippe Bonniaud, Gilles Devouassoux, Stephanie Fry, Laurent Guilleminault, Naji Khayath, Christophe Leroyer, Cecile Chenivesse
Publikováno v:
Airway pharmacology and treatment.
Autor:
Mark C. Liu, Jay Azmi, Gilles Devouassoux, Steven G. Smith, Robert G. Price, Miguel Bergna, Dalal Mouneimne, Bradley E. Chipps, Dmitry V Galkin, Xavier Muñoz, Kenneth R. Chapman, Frank C. Albers
Publikováno v:
Scientia
Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Respiratory Research
Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Respiratory Research
Background The OSMO study assessed the efficacy of switching to mepolizumab in patients with severe eosinophilic asthma that was uncontrolled whilst receiving omalizumab. The objective of this analysis was to assess the proportion of patients achievi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8deb811de3f5f13f4f6b792bc5f97be
https://hdl.handle.net/11351/6793
https://hdl.handle.net/11351/6793
Autor:
Damien Dupont, Bruno Lina, A. Sénéchal, Meja Rabodonirina, Isabelle Durieu, Sébastien Couraud, Tanguy Déméautis, Florence Persat, Gilles Devouassoux, Loïc Simon, Martine Wallon, Eric Dannaoui, Philippe Reix, Rolf Kramer, Jean Menotti, Héloïse Garnier
Publikováno v:
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 2021, 58 (6), pp.106447. ⟨10.1016/j.ijantimicag.2021.106447⟩
International Journal of Antimicrobial Agents, 2021, 58 (6), pp.106447. ⟨10.1016/j.ijantimicag.2021.106447⟩
Resistance of Aspergillus fumigatus to triazoles has been reported increasingly in Europe. As few data are available from Southern France, the objectives of this study were to assess the burden of A. fumigatus isolates with azole resistance from clin